Terns Pharmaceuticals Announces Leadership Transition

Senthil Sundaram Stepping Down as Chief Executive Officer for Health Reasons...

Related Keywords

Senthil Sundaram ,Mark Vignola ,Head Of Research Development ,Head Of Research Development At Terns ,Berry Company Public Relations ,Peritoneal Cancer Foundation ,Company Nasdaq ,Terns Pharmaceuticals ,Terns Pharmaceuticals Inc ,Tern Chief Executive Officer ,Senior Advisor ,Erin Quirk ,Initial Public Offering ,David Fellows ,Western President ,Chief Medical Officer ,Inflation Reduction Act ,Annual Report ,Company Public ,Nasdaq Tern ,Nc ,